(Q41648119)

6 October 2017

1 reference

title

Assessing residual leukaemia (English)

1 reference

6 October 2017

1 reference

Cross NC

1

1 reference

6 October 2017

publication date

1 June 1997

1 reference

Best Practice and Research: Clinical Haematology

6 October 2017

published in

1 reference

6 October 2017

volume

10

1 reference

6 October 2017

issue

2

1 reference

6 October 2017

page(s)

389-403

1 reference

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Detection of minimal residual disease state in chronic myelogenous leukemia patients using fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Detection of the Philadelphia chromosome in interphase nuclei

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Cytogenetic analysis is non-informative for assessing the remission rate in chronic myeloid leukemia (CML) patients on interferon-alpha (IFN-alpha) therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: correlations with acute graft-versus-host disease and relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

bcr/abl mRNA detection following bone marrow transplantation for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Variable numbers of BCR-ABL transcripts persist in CML patients who achieve complete cytogenetic remission with interferon-α

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

False-positive results with PCR to detect leukaemia-specific transcript.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Significance of residual leukaemia transcripts after bone marrow transplant for CML

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Studies of BCR and ABL gene rearrangements in chronic myelogenous leukemia patients by conventional and pulsed-field gel electrophoresis using gel inserts

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. The Leukemia Service

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Apparent decrease and elimination of BCR/ABL mRNA-expressing residual cells in patients with chronic myelogenous leukemia after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Detection of minimal residual disease by polymerase chain reaction of bcr/abl transcripts in chronic myelogenous leukaemia following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Correlation between the proportion of Philadelphia chromosome-positive metaphase cells and levels ofBCR-ABL mRNA in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Quantitative determination of the hybrid Bcr-Abl RNA in patients with chronic myelogenous leukaemia under interferon therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Philadelphia-negative chronic myeloid leukaemia: detection by FISH of BCR-ABL fusion gene localized either to chromosome 9 or chromosome 22

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Detection of minimal residual disease after sex-mismatch bone marrow transplantation in chronic myelogenous leukemia by fluorescence in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Molecular response of CML patients treated with interferon-alpha monitored by quantitative Southern blot analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Philadelphia-negative chronic myelogenous leukemia with breakpoint cluster region rearrangement: molecular analysis, clinical characteristics, and response to therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Value of molecular monitoring during the treatment of chronic myeloid leukemia: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

Detection of bcr-abl fusion in chronic myelogeneous leukemia by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2897%2980014-5

7 January 2021

10.1016/S0950-3536(97)80014-5

Identifiers

DOI

0 references

1 reference